Balanced news tone
News Sentiment
DRIO sentiment intelligence
DarioHealth Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-0.8% over one week, +2.3% over four weeks, trend inactive, and below fair value.
DarioHealth Platform Combines Diabetes and Hypertension Care
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
DarioHealth Platform Combines Diabetes and Hypertension Care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:30
- Source
- Stock Titan
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
DarioHealth Corp. (NASDAQ: DRIO) announced that a Fortune 50 employer has chosen its AI-powered cardiometabolic care platform for over 100,000 eligible employees. This marks Dario's fifth Fortune 50 client, highlighting the growing demand for integrated chronic condition manageme
- Tone
- Positive 91/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 11:13
- Source
- PR Newswire
AI Engine Delivers Engagement Gains as Recurring Revenue Outlook Climbs
DarioHealth Corp. (DRIO:NASDAQ) announced that its DarioIQ AI platform is expected to boost annual Business-to-Business-to-Consumer (B2B2C) recurring revenue from existing customers by 10% to 15%. This growth is driven by the platform's ability to increase member engagement by 40
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 15 Jul 2026 14:11
- Source
- Streetwise Reports
DarioHealth AI Platform Targets 10-15% Revenue Growth from Existing Clients
DarioHealth (DRIO:NASDAQ) anticipates a 10-15% increase in annual B2B2C recurring revenue from existing clients, excluding new customer acquisitions, due to the expanded deployment of its proprietary DarioIQ AI platform. This platform leverages over 13 billion real-world data poi
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 15 Jul 2026 14:10
- Source
- Streetwise Reports
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
DarioHealth Corp. (DRIO) anticipates a 10-15% increase in recurring revenue from its existing customers through the implementation of its proprietary AI engine, DarioIQ™. This announcement was made via a press release highlighted by Quantisnow. The company specializes in health c
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 13 Jul 2026 16:13
- Source
- Quantisnow
DarioHealth (DRIO) Q1 2026 earnings summary
DarioHealth (DRIO) reported its Q1 2026 earnings, showcasing a second consecutive quarter of sequential revenue growth at $5.6 million, driven by expanded partnerships and efficiency. The company added 10 new accounts, building a strong commercial pipeline of $127 million. Despit
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 12 Jul 2026 02:10
- Source
- Quartr
DarioHealth Extends President and CCO Steven Nelson’s Medical Leave Indefinitely – July 2026 8-K Filing Update
DarioHealth Corp. has announced an indefinite extension of President and Chief Commercial Officer Steven Nelson's medical leave, effective July 10, 2026. His duties will be assumed by the senior management team without a named interim replacement, which may cause investor concern
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 11 Jul 2026 01:39
- Source
- Minichart
DarioHealth Corp. (NASDAQ: DRIO) president and CCO on indefinite medical leave
DarioHealth Corp. (NASDAQ: DRIO) announced that its President and Chief Commercial Officer, Steven Nelson, has had his temporary medical leave extended indefinitely as of July 10, 2026. While Nelson remains in his role, his responsibilities are being handled by senior management.
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 10 Jul 2026 21:39
- Source
- Stock Titan
DarioHealth (DRIO) Q4 2025 earnings summary
DarioHealth (DRIO) achieved record new business in 2025, signing 85 new agreements, though Q4 2025 revenue declined year-over-year due to a legacy client nonrenewal. The company reported full-year 2025 revenue
- Tone
- Positive 63/100
- Event
- Earnings
- Published
- 09 Jul 2026 17:11
- Source
- Quartr
Enterprise value to EBIT forward of DarioHealth Corp. – NASDAQ:DRIO
This article provides a brief financial overview for DarioHealth Corp. (NASDAQ: DRIO), focusing on its enterprise value to EBIT forward. It indicates the latest period's value without specifying the actual numbers, suggesting the content is likely a data point from a financial pl
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 16:11
- Source
- TradingView
Digital Health Platform Lands Access to Hundreds of Thousands of Covered Lives
DarioHealth Corp. (DRIO:NASDAQ) has secured a new agreement through its Amwell partnership, making its cardiometabolic platform available to a major Arizona health insurer's Administrative Services Only (ASO) business, impacting hundreds of thousands of covered lives. This expans
- Tone
- Positive 72/100
- Event
- Deals and strategy
- Published
- 09 Jul 2026 10:39
- Source
- Streetwise Reports
DarioHealth (DRIO) Secures Arizona Insurer Deal via Amwell
DarioHealth (DRIO) has announced a new agreement with a major Arizona health insurer, gaining access to hundreds of thousands of covered lives through its strategic partnership with Amwell. This deal highlights the strength of Dario's channel strategy, leveraging Amwell's infrast
- Tone
- Positive 70/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 16:11
- Source
- Streetwise Reports
Enterprise value to revenue forward of DarioHealth Corp. – NASDAQ:DRIO
This article provides a brief mention of DarioHealth Corp. (NASDAQ: DRIO) and its enterprise value to revenue forward. It appears to be an entry point to financial data or analysis found on the TradingView platform. The content primarily consists of navigation, copyright informat
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 03:09
- Source
- TradingView
Price to sales forward of DarioHealth Corp. – BOATS:DRIO
This article displays the "Price to sales forward" metric for DarioHealth Corp. (DRIO) on the BOATS (Blue Ocean Alternative Trade System) platform, available through TradingView. It shows that currently, the market is closed, and no trades have been executed. The content only pre
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 20:39
- Source
- TradingView
Price to earnings forward of DarioHealth Corp. – NASDAQ:DRIO
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 12:53
- Source
- TradingView
DarioHealth Signs Deal With Major Health Insurer in Arizona
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 12:16
- Source
- MT Newswires
DarioHealth signs deal with Arizona health insurer via Amwell
DarioHealth Corp. has secured an agreement with an Arizona health insurer through its partnership with Amwell, providing access to its cardiometabolic solution for hundreds of thousands of covered lives. This deal expands DarioHealth's reach to employer clients for diabetes, hype
- Tone
- Positive 67/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 12:11
- Source
- Investing.com
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
DarioHealth Corp. (NASDAQ: DRIO) announced a new agreement with a major health insurer in Arizona through its strategic partnership with Amwell. This agreement makes Dario's cardiometabolic solution available to hundreds of thousands of covered lives within the insurer's Administ
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 11:11
- Source
- PR Newswire
DarioHealth expands into Arizona insurer’s ASO book through Amwell
DarioHealth (NASDAQ: DRIO) announced a new agreement with a major Arizona health insurer through its Amwell partnership, making its cardiometabolic digital health solution available to hundreds of thousands of covered lives among the insurer’s ASO employer clients. This deal supp
- Tone
- Positive 71/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 11:11
- Source
- Stock Titan
DarioHealth signs deal with Arizona health insurer via Amwell By Investing.com
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 07:00
- Source
- Investing.com Canada
Enterprise value to EBITDA forward of DarioHealth Corp. – NASDAQ:DRIO
This article displays the enterprise value to EBITDA forward for DarioHealth Corp. (NASDAQ: DRIO). It appears to be a financial data point from TradingView, which provides market data and financial tools.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 06:11
- Source
- TradingView
Price to book forward of DarioHealth Corp. – NASDAQ:DRIO
The article focuses on the "Price to book forward" metric for DarioHealth Corp. (NASDAQ: DRIO) as displayed on TradingView. It appears to be a financial data point for the company, accessible through the platform's market and financial analysis tools. The content primarily lists
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 20:10
- Source
- TradingView
DRIO - DarioHealth Corp Latest SEC Filings
This article provides the latest SEC filings and comprehensive financial overview for DarioHealth Corp (DRIO). It includes key financial metrics such as market cap, sales, EPS data, insider and institutional ownership, and various performance indicators. The stock closed at $7.28
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 00:40
- Source
- Finviz
DarioHealth Expands Agreement With US Health Insurer
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 02 Jul 2026 18:45
- Source
- MT Newswires
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
DarioHealth Corp. announced that a top national health insurer has expanded its partnership to include Dario's hypertension solution, following the success of its behavioral health offering. This expansion is expected to approximately triple Dario's revenue opportunity with this
- Tone
- Positive 92/100
- Event
- Earnings
- Published
- 02 Jul 2026 11:40
- Source
- PR Newswire
One of the U.S.'s biggest insurers expands Dario into hypertension
DarioHealth (NASDAQ: DRIO) announced that a major U.S. health insurer extended its agreement and expanded its partnership to include Dario's AI-powered hypertension solution due to the success of its behavioral health program. This expansion into cardiometabolic care is expected
- Tone
- Positive 75/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 11:29
- Source
- Stock Titan
DarioHealth (DRIO) Expands Reach via Beluga Health Deal
DarioHealth (DRIO) has expanded its reach through a collaboration with Beluga Health, integrating its AI-driven multi-condition platform with Beluga's clinical network across all 50 states. This partnership enables DarioHealth to provide provider-backed care for chronic condition
- Tone
- Positive 73/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 16:38
- Source
- Streetwise Reports
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
DarioHealth Corp. has appointed Sean O'Reilly, former Humana Chief Compliance Officer, to its Advisory Board to bolster its strategic growth and healthcare partnerships. O'Reilly's extensive background in healthcare compliance, risk management, and experience with various health
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 01 Jul 2026 16:11
- Source
- PR Newswire
Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market
DarioHealth Corp. (DRIO:NASDAQ), an AI-driven digital health solutions company, announced a strategic partnership with Beluga Health, P.A., to enhance chronic care delivery across all 50 states. This collaboration integrates DarioHealth's multi-condition engagement platform with
- Tone
- Positive 74/100
- Event
- Deals and strategy
- Published
- 01 Jul 2026 13:38
- Source
- Streetwise Reports
DarioHealth adds former Humana compliance chief to board
DarioHealth Corp. (NASDAQ:DRIO) has appointed Sean O’Reilly, former Senior Vice President and Chief Compliance Officer at Humana, to its Advisory Board. This strategic move aims to bolster DarioHealth's channel partner-led growth strategy, leveraging O'Reilly's extensive experien
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 30 Jun 2026 19:10
- Source
- Investing.com